# FDA Inspection 1220575 - Glenmark Pharmaceuticals Ltd. - September 29, 2023

Source: https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/7be8b709-45bd-494b-9fd3-ccb5af97fc9d
Source feed: FDA_Inspections

> FDA Inspection 1220575 for Glenmark Pharmaceuticals Ltd. on September 29, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220575
- Company Name: Glenmark Pharmaceuticals Ltd.
- Inspection Date: 2023-09-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1178125 - 2022-08-04](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/ee2b75c6-a881-4fa2-9105-88213e9e6817)
- [FDA Inspection 1100923 - 2019-06-06](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/6addfe63-a991-4b13-a16e-644c4cf6b3b1)

Company: https://www.keypedia.com/companies/glenmark-pharmaceuticals-ltd/a4f2e97c-6649-4119-b300-12622e51c1fd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c